EyePoint Pharmaceuticals Inc. buy Chardan Capital
Start price
07.05.24
/
50%
€9.92
Target price
07.05.25
€25.98
Performance (%)
-4.42%
Price
25.07.24
€8.38
Summary
This prediction is currently active. With a performance of -4.42%, the BUY prediction for EyePoint Pharmaceuticals Inc. by Chardan_Capital is down slightly. This prediction currently runs until 07.05.25. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
EyePoint Pharmaceuticals Inc. | - | - |
iShares Core DAX® | 1.280% | 1.320% |
iShares Nasdaq 100 | -2.457% | -5.192% |
iShares Nikkei 225® | -2.006% | -1.389% |
iShares S&P 500 | -0.662% | -1.884% |
Comments by Chardan_Capital for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its price target lowered by analysts at Chardan Capital from $39.00 to $28.00. They now have a "buy" rating on the stock.
Ratings data for EYPT provided by MarketBeat
Stopped prediction by Chardan_Capital for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€8.25
28.06.24
28.06.24
€26.15
28.06.25
28.06.25
14.88%
25.07.24
25.07.24
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€11.30
03.08.23
03.08.23
€20.11
03.08.24
03.08.24
-25.84%
25.07.24
25.07.24
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.92
03.03.23
03.03.23
€19.79
03.03.24
03.03.24
797.26%
04.03.24
04.03.24